Legal Opinion
Dr. Falk Pharma Gmbh v. Generico, LLC
Court of Appeals for the Federal Circuit
Decided February 8, 2019No. 2017-2312; 2017-2636, 2018-1320; 2018-2097PublishedCited by 4 opinions
1Opinion of the Court
O'Malley, Circuit Judge.
ORDER
At issue are three motions to disqualify Katten Muchin Rosenman LLP as counsel for Mylan Pharmaceuticals Inc. ("Mylan") in three appeals before this court. Valeant Pharmaceuticals International, Inc. ("Valeant-CA") and Salix Pharmaceuticals, Inc. ("Salix") move to disqualify in Valeant Pharmaceuticals International, Inc. v. Mylan Pharmaceuticals Inc ., No. 2018-2097 (" Valeant II " ), Salix moves to disqualify in Salix Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. , Nos. 2017-2636, 2018-1320 (" Salix II "), and Valeant-CA and Salix move to disqualify in Dr.…
2Cases cited9 opinions
- United States v. Miller, William G.Court of Appeals for the Third Circuit · 1980
- Shaffer v. Farm Fresh, Inc.Court of Appeals for the Fourth Circuit · 1992
- GSI Commerce Solutions, Inc. v. BabyCenter, L.L.C.Court of Appeals for the Second Circuit · 2010
- Atasi Corporation v. Seagate TechnologyCourt of Appeals for the Federal Circuit · 1988
- Manoir-Electroalloys Corp. v. Amalloy Corp.District Court, D. New Jersey · 1989
4 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- United Cannabis Corporation v. Pure Hemp Collective Inc.Court of Appeals for the Federal Circuit · 2023
- Harbour Antibodies BV v. Teneobio, Inc.District Court, D. Delaware · 2024
- Jefferson Street Holdings, LLC v. Otter Products, LLCDistrict Court, D. Colorado · 2023
- Keefe Commissary Network, LLC v. Beazley Insurance Company, Inc.District Court, E.D. Missouri · 2020